RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Clayton Yates to Drug Screening Assays, Antitumor

Back to Details
This is a "connection" page, showing publications Clayton Yates has written about Drug Screening Assays, Antitumor.
Clayton Yates
Connection Strength
0.021
Drug Screening Assays, Antitumor
  1. Karna P, Sharp SM, Yates C, Prakash S, Aneja R. EM011 activates a survivin-dependent apoptotic program in human non-small cell lung cancer cells. Mol Cancer. 2009 Oct 30; 8:93.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support